Bunkerhill Health has secured $55 million in Series B funding to expand its Carebricks platform, which allows hospitals to build and deploy custom AI agents for clinical and administrative tasks.
Key facts
- •Bunkerhill Health raised $55 million in a Series B round led by investors including Khosla Ventures and Sequoia Capital.
- •The Carebricks platform allows health systems to build custom AI agents for clinical, operational, and administrative tasks.
- •UTMB reports that a nephrology triage agent has reduced average specialist wait times by more than 50 percent.
- •A lung nodule agent at UTMB resulted in an 80 percent faster response time for urgent cases.
- •Bunkerhill intends to use the funding to expand the platform's use cases and improve governance and monitoring features.
Bunkerhill Health announced a $55 million Series B funding round today to scale its agentic AI platform, Carebricks. The round included participation from Sequoia Capital, Felicis, Optum Ventures, Y Combinator, and Khosla Ventures. The platform is designed to help health systems move AI models from research sandboxes into live clinical and operational environments.
By the numbers
Platform Capabilities and Adoption
Carebricks enables hospitals to build custom AI agents rather than purchasing off-the-shelf products. These agents perform tasks ranging from reviewing cardiology imaging for heart disease to managing prior authorizations and maintaining registry data. Current users of the platform include the Cleveland Clinic, the University of Texas Medical Branch (UTMB), and Intermountain Health.
Operational Impact at UTMB
The University of Texas Medical Branch currently has over 20 agents live on the platform. Reported results include a 50 percent reduction in average specialist wait times for nephrology triage and an 80 percent faster response time for urgent lung nodule cases. In one instance, a coronary calcium detection agent flagged a patient at risk of a heart attack, leading to a successful triple bypass surgery.
Future Development and Governance
Bunkerhill plans to use the new capital to expand Carebricks into additional clinical and operational use cases. The company is also focusing on building out governance, monitoring, and safeguards, as health systems must manage liability and decision-making protocols when deploying autonomous agents.
Advertisement
This article was independently rewritten by ManyPress editorial AI from reporting originally published by Artificial Intelligence News.
